SMTL ID : 4cre.1

Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.73 Å

Oligo State

homo-trimer

Ligands

3 x MVN: 6-chloro-4-methyl-1H-quinolin-2-one(Non-covalent)

MVN.1: 16 residues within 4Å: Chain A: L.137, D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 Ligands: SO4.6 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.183, A:T.206 Hydrogen bonds: A:G.209, A:G.211 MVN.10: 16 residues within 4Å: Chain B: L.137, D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 Ligands: SO4.15 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:A.183, B:T.206 Hydrogen bonds: B:G.209, B:G.211 MVN.19: 16 residues within 4Å: Chain C: L.137, D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 Ligands: SO4.24 4 PLIP interactions: 4 interactions with chain C Hydrophobic interactions: C:A.183, C:T.206 Hydrogen bonds: C:G.209, C:G.211

24 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: T.5, A.6, Q.146 Ligand excluded by PLIP SO4.3: 2 residues within 4Å: Chain A: K.195, W.200 Ligand excluded by PLIP SO4.4: 8 residues within 4Å: Chain A: K.117, R.120 Chain B: K.117, R.120 Chain C: K.117, R.120 Ligands: SO4.13, SO4.22 Ligand excluded by PLIP SO4.5: 2 residues within 4Å: Chain A: H.82, W.230 Ligand excluded by PLIP SO4.6: 5 residues within 4Å: Chain A: H.44, K.185, G.186, S.188 Ligands: MVN.1 Ligand excluded by PLIP SO4.7: 4 residues within 4Å: Chain A: Y.134, L.137, R.138, K.185 Ligand excluded by PLIP SO4.8: 4 residues within 4Å: Chain A: P.151, Y.176, R.177, E.178 Ligand excluded by PLIP SO4.9: 4 residues within 4Å: Chain A: F.74, V.103, N.104, Q.109 Ligand excluded by PLIP SO4.11: 3 residues within 4Å: Chain B: T.5, A.6, Q.146 Ligand excluded by PLIP SO4.12: 2 residues within 4Å: Chain B: K.195, W.200 Ligand excluded by PLIP SO4.13: 8 residues within 4Å: Chain A: K.117, R.120 Chain B: K.117, R.120 Chain C: K.117, R.120 Ligands: SO4.4, SO4.22 Ligand excluded by PLIP SO4.14: 2 residues within 4Å: Chain B: H.82, W.230 Ligand excluded by PLIP SO4.15: 5 residues within 4Å: Chain B: H.44, K.185, G.186, S.188 Ligands: MVN.10 Ligand excluded by PLIP SO4.16: 4 residues within 4Å: Chain B: Y.134, L.137, R.138, K.185 Ligand excluded by PLIP SO4.17: 4 residues within 4Å: Chain B: P.151, Y.176, R.177, E.178 Ligand excluded by PLIP SO4.18: 4 residues within 4Å: Chain B: F.74, V.103, N.104, Q.109 Ligand excluded by PLIP SO4.20: 3 residues within 4Å: Chain C: T.5, A.6, Q.146 Ligand excluded by PLIP SO4.21: 2 residues within 4Å: Chain C: K.195, W.200 Ligand excluded by PLIP SO4.22: 8 residues within 4Å: Chain A: K.117, R.120 Chain B: K.117, R.120 Chain C: K.117, R.120 Ligands: SO4.4, SO4.13 Ligand excluded by PLIP SO4.23: 2 residues within 4Å: Chain C: H.82, W.230 Ligand excluded by PLIP SO4.24: 5 residues within 4Å: Chain C: H.44, K.185, G.186, S.188 Ligands: MVN.19 Ligand excluded by PLIP SO4.25: 4 residues within 4Å: Chain C: Y.134, L.137, R.138, K.185 Ligand excluded by PLIP SO4.26: 4 residues within 4Å: Chain C: P.151, Y.176, R.177, E.178 Ligand excluded by PLIP SO4.27: 4 residues within 4Å: Chain C: F.74, V.103, N.104, Q.109 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fjellstrom, O. et al., Creating Novel Activated Factor Xi Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design. Plos One (2015)

Release Date

2015-02-11

Peptides

COAGULATION FACTOR XI: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

COAGULATION FACTOR XI

Related Entries With Identical Sequence